These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22985189)

  • 21. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients.
    Dusser D; Vicaut E; Lefrançois G;
    Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers.
    Smyth HD; Hickey AJ
    AAPS PharmSciTech; 2003; 4(3):E38. PubMed ID: 14621970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting physical stability in pressurized metered dose inhalers via dwell and instantaneous force colloidal probe microscopy.
    D'Sa D; Chan HK; Chrzanowski W
    Eur J Pharm Biopharm; 2014 Sep; 88(1):129-35. PubMed ID: 25058596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The surface characterisation and comparison of two potential sub-micron, sugar bulking excipients for use in low-dose, suspension formulations in metered dose inhalers.
    James J; Crean B; Davies M; Toon R; Jinks P; Roberts CJ
    Int J Pharm; 2008 Sep; 361(1-2):209-21. PubMed ID: 18577435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Crosslinked chitosan nanoparticle formulations for delivery from pressurized metered dose inhalers.
    Sharma K; Somavarapu S; Colombani A; Govind N; Taylor KM
    Eur J Pharm Biopharm; 2012 May; 81(1):74-81. PubMed ID: 22245573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of ethanol on the formation and physico-chemical properties of particles generated from budesonide solution-based pressurized metered-dose inhalers.
    Zhu B; Traini D; Chan HK; Young PM
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1625-37. PubMed ID: 24087854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The PulmoSphere™ platform for pulmonary drug delivery.
    Weers J; Tarara T
    Ther Deliv; 2014 Mar; 5(3):277-95. PubMed ID: 24592954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of persistent asthma with Symbicort (budesonide/formoterol inhalation aerosol): an inhaled corticosteroid and long-acting beta2-adrenergic agonist in one pressurized metered-dose inhaler.
    Berger WE; Noonan MJ
    J Asthma; 2010 May; 47(4):447-59. PubMed ID: 20528601
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination.
    LaForce C; Weinstein C; Nathan RA; Weinstein SF; Staudinger H; Meltzer EO
    J Asthma; 2011 Aug; 48(6):625-31. PubMed ID: 21726121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of budesonide/formoterol pressurized metered-dose inhaler versus budesonide pressurized metered-dose inhaler alone in Hispanic adults and adolescents with asthma: a randomized, controlled trial.
    Zangrilli J; Mansfield LE; Uryniak T; O'Brien CD
    Ann Allergy Asthma Immunol; 2011 Sep; 107(3):258-65.e2. PubMed ID: 21875546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the Feasibility of Rugose Lipid Microparticles in Pressurized Metered Dose Inhalers with Established and New Propellants.
    Minootan Z; Wang H; Connaughton P; Lachacz K; Carrigy N; Ordoubadi M; Lechuga-Ballesteros D; Martin AR; Vehring R
    AAPS PharmSciTech; 2024 Apr; 25(4):82. PubMed ID: 38600288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-pressure aerosol suspensions--a novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers.
    Jones SA; Martin GP; Brown MB
    Int J Pharm; 2005 Sep; 302(1-2):154-65. PubMed ID: 16102928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary dispersion formulations: the impact of dispersed powder properties on pressurized metered dose inhaler stability.
    O'Donnell KP; Williams RO
    Drug Dev Ind Pharm; 2013 Mar; 39(3):413-24. PubMed ID: 23216244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plastic bottles as spacers for a pressurized metered-dose inhaler: in vitro characteristics.
    Kissoon N; Teelucksingh S; Blake KV; Kesser B; Murphy SP; Geller D
    West Indian Med J; 2001 Sep; 50(3):189-93. PubMed ID: 11769021
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilation of formoterol administered with budesonide: device and formulation effects.
    Miller CJ; Senn S; Mezzanotte WS
    Contemp Clin Trials; 2008 Mar; 29(2):114-24. PubMed ID: 17625985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Templated open flocs of nanorods for enhanced pulmonary delivery with pressurized metered dose inhalers.
    Engstrom JD; Tam JM; Miller MA; Williams RO; Johnston KP
    Pharm Res; 2009 Jan; 26(1):101-17. PubMed ID: 18758922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A review of the development of Respimat Soft Mist Inhaler.
    Dalby R; Spallek M; Voshaar T
    Int J Pharm; 2004 Sep; 283(1-2):1-9. PubMed ID: 15363496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients.
    Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G
    Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhalable aerosol microparticles with low carrier dosage and high fine particle fraction prepared by spray-freeze-drying.
    Xi Q; Miao J; Cao Z; Wang H
    Int J Pharm X; 2023 Dec; 5():100158. PubMed ID: 36896094
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimizing aerosol delivery by pressurized metered-dose inhalers.
    Rubin BK; Fink JB
    Respir Care; 2005 Sep; 50(9):1191-200. PubMed ID: 16122402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.